<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19495" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chorionic Villus Sampling</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jones</surname>
            <given-names>Taylor M.</given-names>
          </name>
          <aff>Augusta University of Georgia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Montero</surname>
            <given-names>Freddy J.</given-names>
          </name>
          <aff>Medical College of Georgia at Augusta University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Taylor Jones declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Freddy Montero declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19495.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chorionic villus sampling is a prenatal diagnostic test performed between 10 and 13 weeks gestation. This activity reviews the procedure's indications, risks, and techniques and its utility by the interprofessional team.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Evaluate&#x000a0;the indications for chorionic villus sampling.</p></list-item><list-item><p>Identify&#x000a0;the equipment needed for chorionic villus sampling.</p></list-item><list-item><p>Assess&#x000a0;the risks associated with chorionic villus sampling.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19495&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19495">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19495.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chorionic villus sampling is performed to biopsy placental tissue between 10 to 13 weeks gestation for prenatal genetic testing. The primary advantage of chorionic villus sampling is earlier genetic results in pregnancy. This knowledge provides patients with the opportunity to seek counseling for obstetric management and recommendations, early referral to pediatric subspecialists, or earlier and safer methods of pregnancy termination if results are abnormal.</p>
      </sec>
      <sec id="article-19495.s3" sec-type="Indications">
        <title>Indications</title>
        <p>According to the American College of Obstetrics and Gynecology, women of all ages should be offered prenatal assessment for aneuploidy by screening or diagnostic testing regardless of maternal age or other risk factors.<xref ref-type="bibr" rid="article-19495.r1">[1]</xref><xref ref-type="bibr" rid="article-19495.r2">[2]</xref>&#x000a0;Prenatal genetic testing cannot identify all abnormalities, so testing should be focused on the patient&#x02019;s risk, reproductive goals, and preferences. Ideally, genetic testing should be discussed at the first obstetric visit.</p>
        <p>Indications for chorionic villus sampling include.<xref ref-type="bibr" rid="article-19495.r1">[1]</xref><xref ref-type="bibr" rid="article-19495.r3">[3]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Abnormal early genetic screening on a non-invasive prenatal screening, first trimester combined screening, or abnormalities on ultrasound</p>
          </list-item>
          <list-item>
            <p>A prior child with a structural birth defect&#x000a0;</p>
          </list-item>
          <list-item>
            <p>A prior child with autosomal trisomy or sex chromosome aneuploidy&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Advanced maternal or paternal age&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Parental carrier of a chromosomal rearrangement&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Parental aneuploidy or aneuploidy mosaicism&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Parental carrier of a genetic disorder, such as Tay Sachs, Sickle Cell Disease, or Neurofibromatosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19495.s4" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Caution is advised in patients receiving anticoagulation. Maternal alloimmunization is a relative contraindication since the procedure may&#x000a0;cause&#x000a0;more severe fetal hemolytic disease.<xref ref-type="bibr" rid="article-19495.r4">[4]</xref>&#x000a0;In addition, patients with bloodborne infectious diseases, such as human immunodeficiency virus and hepatitis, should be advised of the&#x000a0;possible risk of vertical transmission with prenatal diagnostic testing.</p>
      </sec>
      <sec id="article-19495.s5" sec-type="Equipment">
        <title>Equipment</title>
        <p>The procedure is performed under continuous ultrasound guidance using an aseptic technique. Apart from an ultrasound machine, the following equipment is required:&#x000a0;</p>
        <p>
<bold>Transabdominal Approach</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sterile drape&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Sterile ultrasound probe cover</p>
          </list-item>
          <list-item>
            <p>Chlorhexidine or iodine preparation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>A local anesthetic of your choice (optional)</p>
          </list-item>
          <list-item>
            <p>10 cc and 20 cc syringe</p>
          </list-item>
          <list-item>
            <p>18 gauge or 20 gauge spinal needle&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Sample collection container with transport media&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Transcervical Approach</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sterile speculum</p>
          </list-item>
          <list-item>
            <p>Single tooth tenaculum</p>
          </list-item>
          <list-item>
            <p>Iodine preparation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>10 cc and 20 cc syringe&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Transcervical CVS catheter</p>
          </list-item>
          <list-item>
            <p>Sample collection container with transport media</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19495.s6" sec-type="Personnel">
        <title>Personnel</title>
        <p>The procedure requires a sonographer to scan in real time.</p>
      </sec>
      <sec id="article-19495.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>
<bold>Before the Procedure&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Formal consult with a maternal-fetal medicine specialist&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>If possible, referral for prenatal genetic counseling&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Informed consent after a thorough discussion of risks and benefits with the opportunity for patients to ask questions&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Evaluation of the need for Rhogam in Rh-negative patients&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ultrasound to confirm fetal heart activity, gestational age assessment with crown-rump length measurement, site of cord insertion, and location of the placenta</p>
          </list-item>
          <list-item>
            <p>Ensure all necessary materials are available, including transport media</p>
          </list-item>
        </list>
        <p>
<bold>At the Time of the Procedure</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skilled provider and ultrasonographer&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ensure the patient is comfortable on the examination table&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Make sure lighting is appropriate&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Prepare the abdomen or cervix, depending on the approach</p>
          </list-item>
          <list-item>
            <p>Explain steps to the patient, if they would like, to help alleviate anxiety</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19495.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>The procedure's route is based on provider preference, but the placental location may influence the decision.<xref ref-type="bibr" rid="article-19495.r5">[5]</xref>&#x000a0;In the transabdominal approach, the ideal site exposing the longest axis of the placenta is identified. The patient is supine, and the abdomen is cleaned with a chlorhexidine or iodine solution. Sterile drapes are placed to create a sterile field. A local anesthetic may be used. An 18 or 20-gauge spinal needle is inserted into the placenta under continuous ultrasound guidance. A 20 cc syringe containing collection media is attached to the end of the needle once the stylet is removed. Negative pressure is created, and the needle is moved up and down through the placenta, collecting the tissue. Once the sample is collected, it is evaluated to ensure sufficient chorionic villi are aspirated.</p>
        <p>In the transcervical approach, the patient is placed in a lithotomy position, and a sterile speculum is inserted into the vagina. The cervix is cleaned with an iodine solution. A single tooth tenaculum may be applied to the anterior lip of the cervix to facilitate the passage of the catheter. Under continuous ultrasound guidance, a transcervical CVS catheter is inserted into the placenta. The catheter contains a malleable guidewire with an echogenic tip, which can be identified on ultrasound. Once in the proper location, the stylet is removed, a 20 cc syringe containing media is attached to the end of the catheter, and negative pressure is created. The sample is evaluated for adequacy before ending the procedure. Transcervical CVS can also be performed using small biopsy forceps.<xref ref-type="bibr" rid="article-19495.r6">[6]</xref>&#x000a0;Tissue samples are sent to the laboratory for culturing and further testing, including conventional karyotype, fluorescence in situ hybridization, and chromosomal microarray. Rapid assessment results return in 2&#x000a0;to 4 days, and cultured samples result in 1&#x000a0;to 2 weeks. Families should meet with their providers to discuss further management. Additional ultrasounds may be performed, and MSAFP may be collected at 16 weeks to screen for open neural tube defects.</p>
      </sec>
      <sec id="article-19495.s9" sec-type="Complications">
        <title>Complications</title>
        <p>The risks of chorionic villus sampling are similar to those of amniocentesis and include pregnancy loss, bleeding, infection, rupture of membranes, and uncertain results.&#x000a0;The pregnancy loss rate has decreased with ultrasound guidance and increasing skill and technique; however, chorionic villus sampling has a long learning curve. A systematic review of the complications of chorionic villus sampling determined a total fetal loss of 0.7 percent within 14 days using a transabdominal approach, 1.3 percent within 30 days, and 2 percent for loss anytime during pregnancy. In the amniocentesis group, the total rate of fetal loss within 14 days was 0.6 percent.<xref ref-type="bibr" rid="article-19495.r7">[7]</xref>&#x000a0;Predictors of increased fetal loss include the number of times the needle or catheter is introduced, the experience and skill of the operator, pregnancies after assisted reproductive techniques, and the use of transcervical cannula instead of biopsy forceps.<xref ref-type="bibr" rid="article-19495.r8">[8]</xref><xref ref-type="bibr" rid="article-19495.r9">[9]</xref>&#x000a0;With chorionic villus sampling, there is a possibility of identifying confined placental mosaicism, which occurs in 1-2% of cases.<xref ref-type="bibr" rid="article-19495.r10">[10]</xref>&#x000a0;This occurs when there is a discrepancy between the chromosomal makeup of the placenta and the fetus. The fetus is truly mosaic in 10% of cases, however, the finding of mosaicism is associated with an increased risk of poor placental function and perinatal complications including fetal&#x000a0;growth restriction and maternal hypertension.<xref ref-type="bibr" rid="article-19495.r11">[11]</xref>&#x000a0;Mosaicism should be followed by amniocentesis in the second trimester.&#x000a0;</p>
        <p>Additionally,&#x000a0;limb reduction defects and oromandibular hypogenesis have been described in the literature as risks of chorionic villus sampling.<xref ref-type="bibr" rid="article-19495.r12">[12]</xref>&#x000a0;Early CVS (before 10 weeks gestation) has been identified as a risk factor for these complications. For example, the World Health Organization estimates the risk of limb defects to be about 6 per 10,000, which does not differ from the general population risk.<xref ref-type="bibr" rid="article-19495.r1">[1]</xref><xref ref-type="bibr" rid="article-19495.r13">[13]</xref>&#x000a0;Although the risk is low, it is important to counsel patients about the data when CVS is considered before 10 weeks. Vaginal spotting has been reported in up to 32% of women and is more common after transcervical CVS.<xref ref-type="bibr" rid="article-19495.r1">[1]</xref><xref ref-type="bibr" rid="article-19495.r14">[14]</xref>&#x000a0;The incidence of culture failure, leakage of amniotic fluid, or infection after CVS is reported to be less than 0.5%.</p>
      </sec>
      <sec id="article-19495.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Chorionic villus sampling is a safe and established early diagnostic prenatal genetic testing option. With a skilled provider and the advancement of ultrasound, complications are minimal. The results can help families make informed decisions about their pregnancy.</p>
      </sec>
      <sec id="article-19495.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A maternal-fetal medicine specialist generally performs chorionic villus sampling. Some pregnant patients who are candidates for CVS may present for care to a general obstetrician, family medicine, or internal medicine provider. Given the specific time frame in which a CVS can be performed, early referral to MFM is a key factor in ensuring patients have access to the procedure. Genetic counselors are an additional resource for families, helping them understand risks and options for prenatal testing.&#x000a0;Clear and efficient communication between maternal-fetal medicine specialists and the referring provider is crucial&#x000a0;to ensure a timely discussion of results and outline further pregnancy management recommendations.</p>
      </sec>
      <sec id="article-19495.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19495&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19495">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19495/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19495">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19495.s13">
        <title>References</title>
        <ref id="article-19495.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <article-title>Practice Bulletin No. 162 Summary: Prenatal Diagnostic Testing for Genetic Disorders.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>May</month>
            <volume>127</volume>
            <issue>5</issue>
            <fpage>976</fpage>
            <page-range>976-978</page-range>
            <pub-id pub-id-type="pmid">27101119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <article-title>Practice Bulletin No. 163 Summary: Screening for Fetal Aneuploidy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>May</month>
            <volume>127</volume>
            <issue>5</issue>
            <fpage>979</fpage>
            <page-range>979-981</page-range>
            <pub-id pub-id-type="pmid">27101120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wapner</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Chorionic villus sampling.</article-title>
            <source>Obstet Gynecol Clin North Am</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-110</page-range>
            <pub-id pub-id-type="pmid">9086520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moise</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Increased severity of fetal hemolytic disease with known rhesus alloimmunization after first-trimester transcervical chorionic villus biopsy.</article-title>
            <source>Fetal Diagn Ther</source>
            <year>1990</year>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>76</fpage>
            <page-range>76-8</page-range>
            <pub-id pub-id-type="pmid">2130832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silver</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>MacGregor</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Sholl</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Elesh</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Beaird</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Waldee</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Initiating a chorionic villus sampling program. Relying on placental location as the primary determinant of the sampling route.</article-title>
            <source>J Reprod Med</source>
            <year>1990</year>
            <month>Oct</month>
            <volume>35</volume>
            <issue>10</issue>
            <fpage>964</fpage>
            <page-range>964-8</page-range>
            <pub-id pub-id-type="pmid">2246764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Young</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>von Dadelszen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alfirevic</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Instruments for chorionic villus sampling for prenatal diagnosis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2013</year>
            <month>Jan</month>
            <day>31</day>
            <volume>2013</volume>
            <issue>1</issue>
            <fpage>CD000114</fpage>
            <pub-id pub-id-type="pmid">23440775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mujezinovic</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Alfirevic</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review.</article-title>
            <source>Obstet Gynecol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>687</fpage>
            <page-range>687-94</page-range>
            <pub-id pub-id-type="pmid">17766619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silver</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>MacGregor</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Sholl</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hobart</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Waldee</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>An evaluation of the chorionic villus sampling learning curve.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>163</volume>
            <issue>3</issue>
            <fpage>917</fpage>
            <page-range>917-22</page-range>
            <pub-id pub-id-type="pmid">2403168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Birnie</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Robles de Medina</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sollie</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Pajkrt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bilardo</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2017</year>
            <month>May</month>
            <volume>49</volume>
            <issue>5</issue>
            <fpage>599</fpage>
            <page-range>599-606</page-range>
            <pub-id pub-id-type="pmid">27255564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malvestiti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Agrati</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grimi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pompilii</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Izzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martinoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gaetani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Liuti</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Trotta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maggi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Simoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Grati</surname>
                <given-names>FR</given-names>
              </name>
            </person-group>
            <article-title>Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis.</article-title>
            <source>Prenat Diagn</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>11</issue>
            <fpage>1117</fpage>
            <page-range>1117-27</page-range>
            <pub-id pub-id-type="pmid">26213308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Gitlin</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Patrick</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Crain</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans.</article-title>
            <source>Hum Reprod Update</source>
            <year>2014</year>
            <season>Jul-Aug</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>571</fpage>
            <page-range>571-81</page-range>
            <pub-id pub-id-type="pmid">24667481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mastroiacovo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Botto</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Cavalcanti</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Lalatta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Selicorni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tozzi</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Baronciani</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cigolotti</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Petroni</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Limb anomalies following chorionic villus sampling: a registry based case-control study.</article-title>
            <source>Am J Med Genet</source>
            <year>1992</year>
            <month>Dec</month>
            <day>01</day>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>856</fpage>
            <page-range>856-64</page-range>
            <pub-id pub-id-type="pmid">1481865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <article-title>Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. Centers for Disease Control and Prevention.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>1995</year>
            <month>Jul</month>
            <day>21</day>
            <volume>44</volume>
            <issue>RR-9</issue>
            <fpage>1</fpage>
            <page-range>1-12</page-range>
            <pub-id pub-id-type="pmid">7565548</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19495.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhoads</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Schlesselman</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>de la Cruz</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Desnick</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Golbus</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Ledbetter</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Lubs</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Mahoney</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Pergament</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.</article-title>
            <source>N Engl J Med</source>
            <year>1989</year>
            <month>Mar</month>
            <day>09</day>
            <volume>320</volume>
            <issue>10</issue>
            <fpage>609</fpage>
            <page-range>609-17</page-range>
            <pub-id pub-id-type="pmid">2645520</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
